Registration

TARPLIN STRATEGIES LLC for GENENTECH, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Medicare and Medicaid reimbursement for biotechnology products. Health care reform issues, including comparative effectiveness research. Food and Drug Administration legislative and regulatory issues, including follow on biologics.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN New Assistant Secretary for Legislation/HHS; PrincipalDeputy Assistant Secretary for Legislation/HHSStaff Director, Senate Subcommittee on Childrenand Families

Health Issues HCR

Medicare and Medicaid reimbursement for biotechnology products. Health care reform issues, including comparative effectiveness research. Food and Drug Administration legislative and regulatory issues, including follow on biologics.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN New Assistant Secretary for Legislation/HHS; PrincipalDeputy Assistant Secretary for Legislation/HHSStaff Director, Senate Subcommittee on Childrenand Families

Medicare/Medicaid MMM

Medicare and Medicaid reimbursement for biotechnology products. Health care reform issues, including comparative effectiveness research. Food and Drug Administration legislative and regulatory issues, including follow on biologics.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN New Assistant Secretary for Legislation/HHS; PrincipalDeputy Assistant Secretary for Legislation/HHSStaff Director, Senate Subcommittee on Childrenand Families

Medical/Disease Research/Clinical Labs MED

Medicare and Medicaid reimbursement for biotechnology products. Health care reform issues, including comparative effectiveness research. Food and Drug Administration legislative and regulatory issues, including follow on biologics.

LobbyistCovered position, as disclosed
RICHARD JOSEPH TARPLIN New Assistant Secretary for Legislation/HHS; PrincipalDeputy Assistant Secretary for Legislation/HHSStaff Director, Senate Subcommittee on Childrenand Families

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ROCHE HOLDING, LTD. C/O HOFFMANN-LA ROCHE AG Switzerland Switzerland 56.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.